Tradestie Institutional Equity Comparison Engine

MNKD vs MESO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MNKD Overall Edge

MNKD Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mannkind Corporation (MNKD) driven by superior Valuation, Growth & Margin, Options & Structure while MESO counters with relative strength in Momentum & Technical. Fundamentally, MNKD trades at 26.2x Forward P/E with -3.4% operating margin (+24.0% YoY revenue) versus MESO at N/M Forward P/E and -42.6% operating margin (+390.7% YoY). In options structure, MNKD sits in CONSOLIDATION (7th %ile IV; Dealer Gamma Walls on Pro) against MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner MNKD
MNKD 26.2x vs MESO N/M Fwd P/E
Growth & Margin Winner MNKD
Op Margin -3.4% vs -42.6% ยท YoY +24.0% vs +390.7%
Momentum & Technical Winner MESO
1Y -22.9% vs -16.4% ยท 52W Pos 39% vs 6%
Options & Structure Winner MNKD
CONSOLIDATION (7th %ile IV) vs UNCLASSIFIED (37th %ile IV)
MNKD NASDAQ
Mannkind Corporation
Pharmaceutical Preparations
$3.91
-5.33% 1D
Market Cap $1.3B
1M Return +28.62%
1Y Return -22.88%
Forward P/E 26.2x
Unified AI Score
38.4 / 100 SELL
Tech 8.0 Fund 38.0 Flow 72.0 Mom 54.0
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MNKD -22.88% MESO -16.42% Spread: +6.46 pp (MESO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MNKD TTM Op. Margin: -3.4% MESO TTM Op. Margin: -42.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MNKD vs MESO. Trailing 12-month operating profitability (MNKD -3.4% vs MESO -42.6%) and valuation multiples (MNKD 26.2x vs MESO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MNKD (8) vs MESO (2)
Institutional Metric MNKD MESO Criterion Row Winner
Market Capitalization Scale $1.3B $1.7B Larger Scale MESO
Trailing P/E Ratio Valuation 32.3x N/M Lower Multiple MNKD
Forward P/E Ratio Valuation 26.2x N/M Lower Multiple MNKD
Revenue Growth (YoY) Growth +24.0% +390.7% Higher Growth MESO
Operating Margin (TTM) Profitability -3.4% -42.6% Higher Margin MNKD
Net Profit Margin Profitability -18.1% -47.8% Higher Margin MNKD
Return on Equity (ROE) Capital Efficiency 0.0% -9.9% Higher ROE MNKD
52-Week Range Position Momentum 39% ($2โ€“$7) 6% ($12โ€“$22) Stronger Trend MNKD
Beta / 30D Volatility Risk Regime 1.29ฮฒ ยท 48% Vol 1.18ฮฒ ยท 78% Vol Lower Realized Risk MNKD
Unified Institutional Score Composite Signal 38.4 / 100 (SELL) 35.5 / 100 (SELL) Higher Composite MNKD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MNKD vs MESO Buy Guide
MNKD CONSOLIDATION
95d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 7th %ile
IV Regime Compressed (<25th %ile)
Live MNKD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MNKD nor MESO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.